The authors omitted a grant from the National Institutes of Health (NIH, #R01AI148407) in the Acknowledgments section. The corrected version appears below. The authors apologise for this error.
ACKNOWLEDGMENTS
We thank staff from the flow cytometry facilities at the Department of Microbiology and Immunology at the Peter Doherty Institute. We thank Dr Lars Kjer-Nielsen for his role in the provision of C1R.MR1 mutants used in TCR ala-scan experiments, Associate Professor Andreas Behren (Olivia Newton-John Cancer Research Institute, Australia) for provision of human melanoma “LM-MEL” cell lines and Professor David Fairlie (University of Queensland, Australia) for the provision of 5-OP-RU and 5-amino-6-d-ribitylaminouracil. This work was supported by the Australian Research Council (ARC; CE140100011 and DP170102471), the National Health and Medical Research Council of Australia (NHMRC; 1113293, 1159932 and 2003192) and the National Institutes of Health (NIH, R01AI148407). NAG and HEGM were supported by ARC DECRA Fellowships (DE210100705 and DE170100575). DIG was supported by an NHMRC Senior Principal Research Fellowship (1117766). JAV was supported by an NHMRC Principal Research Fellowship (1154502). Open access publishing facilitated by The University of Melbourne, as part of the Wiley - The University of Melbourne agreement via the Council of Australian University Librarians.